fda warning letters compounded semaglutide telehealth 2024 2025 Issues Warnings Against Illegal GLP-1 Marketing Dr. Elizabeth Kazarian, MD |

IDF Diabetes Atlas, 9th Edition

Makes Unrealistic Promises: Be skeptical of claims like "lose 30 pounds in 30 days" or guarantees of specific results

Once in use, the medication can typically remain at room temperature for up to 21 days, though refrigeration extends stability

Early-phase human studies (including data in healthy older adults) have been conducted, but robust clinical evidence supporting its use in confirmed GH deficiency or any other licensed indication is lacking

That's why we're putting our collective experience down on paper

Phase 2 in T2D (November 2025): - Subcutaneous amycretin achieved up to 14.5% weight loss vs